» Articles » PMID: 17645692

Effects of Combination of Melatonin and Dexamethasone on Secondary Injury in an Experimental Mice Model of Spinal Cord Trauma

Overview
Journal J Pineal Res
Publisher Wiley
Specialty Endocrinology
Date 2007 Jul 25
PMID 17645692
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigates the effects of combination therapy with melatonin and dexamethasone on the degree of spinal cord injury caused by the application of vascular clip in mice. Spinal cord injury in mice resulted in severe trauma, characterized by edema, neutrophil infiltration, and apoptosis (measured by terminal deoxynucleotidyltransferase-mediated UTP end labeling staining, and immunoreaction of Bax, Bcl-2, and Fas Ligand). Infiltration of the spinal cord tissue with neutrophils (measured as increase in myeloperoxidase activity) was associated with enhanced immuno- histochemical and functional alterations revealed, respectively, by an increased of tumor necrosis factor (TNF)-alpha immunoreactivity, NOS as well as nitrotyrosine and loss of hind leg movement in spinal cord injury (SCI)-operated mice. In contrast, the degree of neutrophil infiltration at different time points, cytokine expression, histologic damage iNOS expression, apoptosis, was markedly reduced in the tissues obtained from SCI-treated mice with the combination therapy, and the motor recovery was also ameliorated. No anti-inflammatory effect was observed in animals treated with melatonin (10 mg/kg) or with dexamethasone (0.025 mg/kg) alone. This study shows that the combination therapy with melatonin and dexamethasone reduces the degree of secondary damage associated with spinal cord injury in mice, and supports the possible use of melatonin in combination with steroids to reduce the dose and the side effects related with the use of steroids for the management of inflammatory disease.

Citing Articles

Effect of local epidural application of methylprednisolone acetate on time to ambulation in non-ambulatory dogs with thoracolumbar intervertebral disc disease: A prospective randomised, blinded control trial.

Natsios P, Golini L, Park B, Steffen F Vet Rec. 2024; 196(5):e4962.

PMID: 39727220 PMC: 11869356. DOI: 10.1002/vetr.4962.


From single to combinatorial therapies in spinal cord injuries for structural and functional restoration.

Doncel-Perez E, Guizar-Sahagun G, Grijalva-Otero I Neural Regen Res. 2024; 20(3):660-670.

PMID: 38886932 PMC: 11433899. DOI: 10.4103/NRR.NRR-D-23-01928.


Melatonin, a natural antioxidant therapy in spinal cord injury.

Xie L, Wu H, Huang X, Yu T Front Cell Dev Biol. 2023; 11:1218553.

PMID: 37691830 PMC: 10485268. DOI: 10.3389/fcell.2023.1218553.


Research Progress of Antioxidants in Oxidative Stress Therapy after Spinal Cord Injury.

Zhang C, Zhai T, Zhu J, Wei D, Ren S, Yang Y Neurochem Res. 2023; 48(12):3473-3484.

PMID: 37526867 DOI: 10.1007/s11064-023-03993-x.


Anesthesia and analgesia for common research models of adult mice.

Ahmadi-Noorbakhsh S, Farajli Abbasi M, Ghasemi M, Bayat G, Davoodian N, Sharif-Paghaleh E Lab Anim Res. 2022; 38(1):40.

PMID: 36514128 PMC: 9746144. DOI: 10.1186/s42826-022-00150-3.